TRVI vs WDAY · $2.32B cap vs P/E 135, rev $5.19B
Trevi Therapeutics Inc (TRVI) versus Workday Inc (WDAY) — a side-by-side from cached financials, not a winner call.
Trevi Therapeutics Inc (TRVI) is a biotechnology company listed on NASDAQ.
Workday Inc (WDAY) is a software - application company listed on US.
TRVI does not have a complete income-statement cache yet.
Latest reported WDAY revenue for 2026-07-31 was $5.19B. Net income was $854.0M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
TRVI currently screens at market cap $2.32B. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
Not investment advice. Open the TRVI and WDAY stock pages for the full models.
Not investment advice.